What is Gujarat Terce Laboratories share price return in the past 10 years?

Gujarat Terce Laboratories Ltd share price has appreciated 24.1% annually (CAGR) over the past ten years.

What is the P/E ratio of Gujarat Terce Laboratories?

The latest standalone P/E ratio of Gujarat Terce Laboratories as of 18-Apr-2024 is 93.78.

What is the P/B ratio of Gujarat Terce Laboratories?

The latest standalone P/B ratio of Gujarat Terce Laboratories as of 18-Apr-2024 is 7.20.

What is the 52-week high and low of Gujarat Terce Laboratories?

The 52-week high of Gujarat Terce Laboratories is Rs. 70.91 and the 52-week low is Rs. 16.65.

What is the TTM revenue of Gujarat Terce Laboratories?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Gujarat Terce Laboratories is Rs. 48.66 (Cr.).

Gujarat Terce Laboratories Ltd - Stock Valuation and Financial Performance

Name: Gujarat Terce Laboratories
Brand: Gujarat Terce Laboratories

BSE: 524314 | NSE: | Pharmaceuticals & Drugs | Small Cap

Place order

Guj. Terce Lab Share Price

₹63.70 3.03 4.99%
as on 18-Apr'24 16:01

DeciZen - make an informed investing decision on Guj. Terce Lab

Based on:

Data

M-Cap below 100cr DeciZen not available

Gujarat Terce Laboratories stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

93.78

Market Cap:

47.3 Cr.

52-wk low:

16.7

52-wk high:

70.9

Is Gujarat Terce Laboratories Ltd an attractive stock to invest in?

1. Is Gujarat Terce Laboratories Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Gujarat Terce Laboratories Ltd is a below average quality company.

2. Is Gujarat Terce Laboratories Ltd undervalued or overvalued?

The key valuation ratios of Gujarat Terce Laboratories Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Gujarat Terce Laboratories Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Gujarat Terce Laboratories Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Guj. Terce Lab:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
ROCE % ⓘ	2.7%	2%	-2.2%	1.2%	2.4%	5.5%	3.8%	-18.9%	8.3%	-7.9%	-
Value Creation Index ⓘ	-0.8	-0.9	-1.2	-0.9	-0.8	-0.6	-0.7	-2.4	-0.4	-1.6	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	28.9	26.5	25	25.3	29	31	37.5	25.2	40.1	46.8	49
Sales YoY Gr.	-	-8.2%	-5.6%	1.2%	14.7%	7%	21%	-32.9%	59.4%	16.6%	-
Adj EPS ⓘ	0.3	0.1	-0.9	-0	0.2	0.6	0.4	-3.7	1.2	-2.3	0.7
YoY Gr.	-	-62.5%	-858.3%	NA	NA	141.7%	-36.2%	-1100%	NA	-294%	-
BVPS (₹) ⓘ	14.7	14.9	14	13.6	14	14.6	15	10.3	11.5	9.3	8.9
Adj Net Profit ⓘ	0.2	0.1	-0.7	0	0.2	0.4	0.3	-2.8	0.9	-1.7	1
Cash Flow from Ops. ⓘ	0.5	1.4	0.2	0.2	4.6	-0.6	-1.6	-0.2	-0.4	0	-
Debt/CF from Ops. ⓘ	19	6	44.1	29	0.1	-1.1	-1.6	-29	-15.1	272.4	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	5.5%	10%	7.6%	16.6%
Adj EPS ⓘ	-224.2%	-256.5%	-282.5%	-294%
BVPSⓘ	-5.1%	-8%	-14.8%	-19.6%
Share Price	24.1%	47.5%	103%	212%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
Return on Equity % ⓘ	2.2	0.8	-6.3	-0.2	1.7	4.1	2.5	-29.3	10.6	-21.7	7.5
Op. Profit Mgn % ⓘ	3.3	2.9	0.7	0.3	1.1	1.6	1.8	-10.3	2.8	-4.6	0.1
Net Profit Mgn % ⓘ	0.8	0.3	-2.7	-0.1	0.6	1.4	0.7	-10.9	2.1	-3.6	1
Debt to Equity ⓘ	0.8	0.7	0.7	0.7	0	0.1	0.2	0.6	0.8	1.1	-
Working Cap Days ⓘ	224	247	256	246	209	196	178	271	176	163	53
Cash Conv. Cycle ⓘ	128	145	151	146	94	59	60	98	62	54	-3

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 7.50%

Sales growth is good in last 4 quarters at 14.32%

Sales growth has been subdued in last 3 years 7.61%

Net Profit has been subdued in last 3 years -282.53%

Debt to equity has increased versus last 3 years average to 1.06

Latest Financials - Gujarat Terce Laboratories Ltd.

	Standalone	Consolidated
TTM EPS (₹)	0.7	-
TTM Sales (₹ Cr.)	48.7	-
BVPS (₹.) ⓘ	8.9	-
Reserves (₹ Cr.) ⓘ	-1	-
P/BV ⓘ	7.20	-
PE ⓘ	93.78	-

From the Market
52 Week Low / High (₹)	16.65 / 70.91
All Time Low / High (₹)	0.50 / 70.91
Market Cap (₹ Cr.)	47.3
Equity (₹ Cr.)	7.4
Face Value (₹)	10
Industry PE ⓘ	47.6

Management X-Ray of Guj. Terce Lab:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Guj. Terce Lab

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Guj. Terce Lab

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Sales	28.85	26.48	24.99	25.29	29.01	31.03	37.54	25.18	40.13	46.78
Operating Expenses ⓘ	27.90	25.70	24.83	25.21	28.69	30.54	36.86	27.95	39.02	48.95
Manufacturing Costs	0.25	0.40	0.38	0.37	0.52	0.68	0.97	0.72	1.55	1.72
Material Costs	13.72	10.28	9.57	9.66	10.52	11.53	13.17	9.67	14.34	18.19
Employee Cost	7.22	8.71	10.38	10.64	11.93	12.82	14.81	12.63	15.49	20.24
Other Costs ⓘ	6.70	6.31	4.50	4.54	5.73	5.51	7.91	4.93	7.63	8.80
Operating Profit ⓘ	0.95	0.78	0.16	0.08	0.32	0.49	0.68	-2.77	1.12	-2.16
Operating Profit Margin (%)	3.3%	2.9%	0.7%	0.3%	1.1%	1.6%	1.8%	-11.0%	2.8%	-4.6%
Other Income ⓘ	0.13	0.08	0.19	0.44	0.41	0.32	0.29	0.80	0.31	0.35
Interest ⓘ	0.41	0.41	0.38	0.31	0.23	0.25	0.29	0.39	0.40	0.72
Depreciation ⓘ	0.33	0.16	0.19	0.19	0.19	0.21	0.24	0.18	0.28	0.36
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	0.34	0.29	-0.22	0.02	0.33	0.35	0.44	-2.53	0.75	-2.89
Tax ⓘ	0.10	0.20	0.46	0.04	0.05	-0.09	0.16	-0.01	-0.13	-1.22
Profit After Tax	0.24	0.09	-0.67	-0.01	0.27	0.43	0.28	-2.52	0.87	-1.67
PAT Margin (%)	0.8%	0.3%	-2.7%	-0.1%	0.9%	1.4%	0.7%	-10.0%	2.2%	-3.6%
Adjusted EPS (₹)	0.3	0.1	-0.9	0.0	0.4	0.6	0.4	-3.4	1.2	-2.3
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Equity and Liabilities
Shareholders Fund	10.94	11.03	10.36	10.06	10.40	10.83	11.11	7.66	8.53	6.86
Share Capital ⓘ	7.42	7.42	7.42	7.42	7.42	7.42	7.42	7.42	7.42	7.42
Reserves ⓘ	3.52	3.61	2.94	2.64	2.98	3.41	3.69	0.24	1.11	-0.56
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	8.61	8.09	7.12	6.99	0.34	0.65	2.53	4.57	6.07	6.44
Long Term Debt	5.70	5.50	5.54	5.49	0.16	0.13	0.16	0.42	2.30	1.46
Short Term Debt	2.91	2.59	1.58	1.51	0.18	0.52	2.38	4.14	3.77	4.98
Trade Payables	2.21	2.49	2.42	1.58	3.32	2.81	3.19	2.85	4.03	5.85
Others Liabilities ⓘ	4.16	4.69	4.57	5.02	5.40	5.04	5.51	6.62	8.46	7.85
Total Liabilities ⓘ	25.92	26.30	24.47	23.66	19.47	19.34	22.34	21.70	27.09	27
Fixed Assets
Gross Block	9.29	9.72	9.78	9.79	5.23	5.62	6.10	6.16	8.28	8.33
Accumulated Depreciation	3.14	3.24	3.43	3.62	3.35	3.56	3.80	3.71	3.99	4.35
Net Fixed Assetsⓘ	6.15	6.48	6.34	6.17	1.88	2.06	2.29	2.45	4.29	3.99
CWIP ⓘ	0	0	0	0	0	0	0	0	0	0
Investmentsⓘ	0	0.30	0.30	0.24	0.27	0.29	0.27	0.27	1.77	0.27
Inventories	4.22	4.02	4.27	3.97	3.79	3.78	3.43	3.74	6.43	4.43
Trade Receivables	9.21	9.20	8.48	7.92	4.58	4.53	7.01	5.17	5.47	7.99
Cash Equivalents	1.13	1.86	0.47	0.53	0.73	0.18	0.04	1.29	0.01	2.03
Others Assetsⓘ	5.21	4.44	4.60	4.82	8.21	8.50	9.30	8.77	9.11	8.30
Total Assets ⓘ	25.92	26.30	24.47	23.66	19.47	19.34	22.34	21.70	27.09	27

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Cash Flow From Operating Activity ⓘ	0.46	1.38	0.16	0.24	4.58	-0.61	-1.59	-0.16	-0.44	0.03
PBT ⓘ	0.34	0.26	-0.22	0.02	0.33	0.35	0.44	-2.52	0.75	-2.89
Adjustment ⓘ	0.61	0.54	0.39	0.08	0.05	0.22	0.25	0.57	0.60	1.02
Changes in Working Capital ⓘ	-0.49	0.69	0.48	0.45	4.3	-1.04	-2.17	1.94	-1.69	1.94
Tax Paid ⓘ	0	-0.11	-0.49	-0.31	-0.10	-0.13	-0.10	-0.15	-0.10	-0.04
Cash Flow From Investing Activity ⓘ	-0.27	0.08	-0.13	0.18	1.11	-0.13	-0.27	-0.42	-2.37	0.62
Capex	-0.16	-0.46	-0.06	-0.01	-0.13	-0.40	-0.48	-0.50	-2.11	-0.06
Net Investments	0	-0.30	0	0.06	-0.19	-0.02	0.02	-0.02	-1.50	0
Others ⓘ	-0.11	0.84	-0.07	0.14	1.43	0.28	0.19	0.10	1.25	0.68
Cash Flow From Financing Activityⓘ	-0.75	-0.73	-1.43	-0.36	-5.49	0.20	1.72	1.83	1.53	-0.12
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	-0.78	0	-0.03	-0.05	-5.17	0.11	0.16	0.37	1.88	-0.84
Interest Paid ⓘ	-0.41	-0.41	-0.38	-0.31	-0.23	-0.25	-0.29	-0.28	-0.40	-0.72
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0.44	-0.32	-1.02	0	-0.09	0.34	1.85	1.74	0.06	1.44
Net Cash Flow ⓘ	-0.56	0.73	-1.39	0.06	0.20	-0.55	-0.14	1.24	-1.28	0.52

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Ratios
ROE (%)	2.22	0.83	-6.3	-0.15	2.65	4.07	2.52	-26.85	10.77	-21.71
ROCE (%)	3.8	3.62	0.88	1.93	3.96	5.38	5.77	-16.4	8.31	-14.81
Asset Turnover Ratio	1.15	1.03	0.98	1.05	1.35	1.6	1.8	1.14	1.65	1.73
PAT to CFO Conversion(x)	1.92	15.33	N/A	N/A	16.96	-1.42	-5.68	N/A	-0.51	N/A
Working Capital Days
Receivable Days	86	125	129	118	79	54	56	88	48	53
Inventory Days	73	56	61	60	49	45	35	52	46	42
Payable Days	53	83	94	76	85	97	83	114	87	99

Gujarat Terce Laboratories Ltd Stock News

Gujarat Terce Laboratories Ltd FAQs

What is the share price of Guj. Terce Lab?

Company share prices are keep on changing according to the market conditions. The closing price of Guj. Terce Lab on 18-Apr-2024 16:01 is ₹63.70.

What is the market cap of Guj. Terce Lab?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 18-Apr-2024 16:01 the market cap of Guj. Terce Lab stood at ₹47.27.

What is the P/E ratio of Guj. Terce Lab?

The latest P/E ratio of Guj. Terce Lab as of 18-Apr-2024 16:01 is 93.78.

What is the P/B ratio of Guj. Terce Lab?

The latest P/B ratio of Guj. Terce Lab as of 18-Apr-2024 16:01 is 7.20.

What is the 52-week high and low of Guj. Terce Lab?

The 52-week high of Guj. Terce Lab is ₹70.91 and the 52-week low is ₹16.65.

What is the TTM revenue of Guj. Terce Lab?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Guj. Terce Lab is ₹48.66 ( Cr.) .

About Gujarat Terce Laboratories Ltd

Gujarat Terce Laboratories is engaged in the manufacturing of tablets, capsules, syrup and injections pertaining to the product group, pharmaceutical formulations and ayurvedic medicines. The company is selling its product in the domestic as well as international market.

The companyâ€™s registered office and factory are located at Bileshwarpura, Gandhinagar in Gujarat. Installed capacity of the company is 270 million tablets and 108 million capsules per annum.

Product list of the company includes: